Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:CNTG

Centogene (CNTG) Stock Price, News & Analysis

Centogene logo

About Centogene Stock (NASDAQ:CNTG)

Key Stats

Today's Range
N/A
50-Day Range
$0.07
$0.35
52-Week Range
N/A
Volume
8.36 million shs
Average Volume
150,868 shs
Market Capitalization
$8.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Centogene N.V., together with its subsidiaries, provides pharmaceutical solutions and diagnostic tests in Europe, the Middle East, North America, Latin America, and the Asia Pacific. The company offers data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It provides CENTOGENE MOx 2.0, a single-step multiomic solution that combines DNA sequencing, biochemical testing, and RNA sequencing; CentoCloud, a cloud-based Software as a Service platform, which enables laboratories to analyze, interpret, and report genomic variants for rare disease diagnostics; FilterTool, a web-based application for genetic data interpretation; and NEW CentoGenome, a Next Generation Sequencing (NGS)-based assay that provides diagnostic information to accelerate access to potential treatment options. The company also offers target and drug screening, clinical development, and market access and expansion, as well as CENTOGENE Biodatabank licenses and insight reports. In addition, it provides early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services, such as whole exome sequencing, whole genome sequencing, and multiomic testing solutions to physicians, laboratories, and hospitals directly or through distributors. The company was founded in 2006 and is headquartered in Rostock, Germany.

Receive CNTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Centogene and its competitors with MarketBeat's FREE daily newsletter.

CNTG Stock News Headlines

Nvidia warning urgent
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
CNTGF Centogene N.V.
Centogene N.V. (CNTG)
Centogene B V (CNTGF)
CENTOGENE Receives Delisting Notice From Nasdaq
See More Headlines

CNTG Stock Analysis - Frequently Asked Questions

Centogene (NASDAQ:CNTG) issued its quarterly earnings results on Wednesday, November, 24th. The company reported ($1.08) earnings per share for the quarter, missing the consensus estimate of ($0.59) by $0.49. The firm had revenue of $35.60 million for the quarter, compared to analyst estimates of $31.91 million.

Centogene (CNTG) raised $60 million in an IPO on Thursday, November 7th 2019. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. SVB Leerink and Evercore ISI acted as the underwriters for the IPO and Baird and BTIG were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Centogene investors own include Avino Silver & Gold Mines (ASM), Avino Silver & Gold Mines (ASM), Lincoln National (LNC), Advanced Micro Devices (AMD), Applied Genetic Technologies (AGTC), Catalyst Pharmaceuticals (CPRX) and Fulcrum Therapeutics (FULC).

Company Calendar

Last Earnings
11/24/2021
Today
11/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical laboratories
Sub-Industry
Healthcare
Current Symbol
NASDAQ:CNTG
Fax
N/A
Employees
810
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$48.54 million
Book Value
($1.01) per share

Miscellaneous

Free Float
N/A
Market Cap
$8.80 million
Optionable
Not Optionable
Beta
-0.67
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

This page (NASDAQ:CNTG) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners